Metabolic mechanisms of cognitive decline in aging and AD mediated by inflammatory PGE2 signaling

炎症 PGE2 信号介导的衰老和 AD 认知能力下降的代谢机制

基本信息

  • 批准号:
    10590390
  • 负责人:
  • 金额:
    $ 192.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-02-01 至 2026-01-31
  • 项目状态:
    未结题

项目摘要

Metabolic mechanisms of cognitive decline in aging and AD mediated by inflammatory PGE2 signaling Project Summary Aging is characterized by the development of maladaptive immune responses that promote cognitive decline and Alzheimer’s disease (AD). We recently identified the inflammatory lipid messenger prostaglandin E2 (PGE2), signaling through its EP2 receptor, as a major driver of age-associated inflammation and cognitive decline. Genetic deletion of the EP2 receptor in myeloid cells was sufficient to prevent systemic and brain inflammation and cognitive decline in aging mice. Myeloid EP2 deletion rescued healthy immune cell responses by restoring glucose flux and downstream mitochondrial respiration in aging macrophages and microglia. We also made the surprising observation that peripheral inhibition of EP2 signaling with a non-brain penetrant EP2 antagonist phenocopied the effect of pan-myeloid EP2 genetic deletion. These data suggest that peripheral inhibition of pro-inflammatory PGE2 signaling is sufficient to restore healthy hippocampal function in aging mice. In this proposal, we will build on these initial findings and define how metabolically reprogrammed myeloid cells in the periphery can elicit effects beyond the blood-brain barrier (BBB) that reverse changes in hippocampal function in models of aging and AD pathology. We will test the hypothesis that the beneficial immune-metabolic effects of EP2 inhibition on myeloid cells in the periphery are transmitted from the blood to the cerebral endothelium and then to astrocytes, leading to improved astrocytic support of neurons. We will employ preclinical models of aging and mutant APP lines, targeted metabolomics and transcriptomics to understand how improving peripheral myeloid energy metabolism leads to beneficial effects beyond the blood brain barrier. We will test whether peripheral EP2 immune blockade, by reprogramming circulating blood, will improve endothelial function. We will then test whether astrocytes, whose foot processes envelop the capillary bed are in turn functionally improved. As astrocytes support neuronal metabolism, we hypothesize that peripheral EP2 inhibition will improve astrocytic support of neurons, leading to improved cognitive function in models of aging and AD.
炎症 PGE2 信号介导的衰老和 AD 认知能力下降的代谢机制 项目概要 衰老的特点是适应不良的免疫反应的发展,从而促进认知能力下降 我们最近发现了炎症脂质信使前列腺素 E2。 (PGE2),通过其 EP2 受体发出信号,是与年龄相关的炎症和认知的主要驱动因素 骨髓细胞中 EP2 受体的基因缺失足以预防全身和大脑的衰退。 衰老小鼠的炎症和认知能力下降挽救了健康的免疫细胞。 通过恢复衰老巨噬细胞中的葡萄糖通量和下游线粒体呼吸来做出反应 我们还做出了令人惊讶的观察,即非脑外周神经元对 EP2 信号传导的抑制。 渗透性 EP2 拮抗剂表型复制了全髓系 EP2 基因缺失的影响。 促炎 PGE2 信号传导的外周抑制足以恢复健康的海马 在本提案中,我们将在这些初步发现的基础上定义代谢的机制。 外周粒细胞重新编程可以引发血脑屏障(BBB)之外的效应 逆转衰老和 AD 病理模型中海马功能的变化我们将检验这一假设。 EP2 抑制对外周骨髓细胞的有益免疫代谢作用可以传递 从血液到脑内皮,然后到星形胶质细胞,从而改善星形胶质细胞的支持 我们将采用衰老和突变 APP 系的临床前模型、靶向代谢组学和 转录组学以了解改善外周骨髓能量代谢如何产生有益效果 我们将通过重编程来测试外周EP2免疫是否被阻断。 然后,我们将测试足突的星形胶质细胞是否会改善内皮功能。 由于星形胶质细胞支持神经元代谢,因此包围毛细血管床的功能也得到改善。 研究表明,外周 EP2 抑制将改善神经元的星形胶质细胞支持,从而改善 衰老和 AD 模型中的认知功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Katrin I. Andreasson其他文献

Katrin I. Andreasson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Katrin I. Andreasson', 18)}}的其他基金

The role of peripheral versus brain myeloid immunity in the cognitive decline of aging and Alzheimer's disease
外周与脑髓免疫在衰老和阿尔茨海默病认知能力下降中的作用
  • 批准号:
    10524957
  • 财政年份:
    2022
  • 资助金额:
    $ 192.36万
  • 项目类别:
Modulating the post-stroke inflammatory response to improve outcome in models of cerebral ischemia
调节中风后炎症反应以改善脑缺血模型的结果
  • 批准号:
    10055756
  • 财政年份:
    2020
  • 资助金额:
    $ 192.36万
  • 项目类别:
The impact of early Tau pathology on cognitive progression and neuropsychiatric symptoms in Parkinson's disease
早期 Tau 病理学对帕金森病认知进展和神经精神症状的影响
  • 批准号:
    10246979
  • 财政年份:
    2019
  • 资助金额:
    $ 192.36万
  • 项目类别:
The impact of early Tau pathology on cognitive progression and neuropsychiatric symptoms in Parkinson's disease
早期 Tau 病理学对帕金森病认知进展和神经精神症状的影响
  • 批准号:
    10468837
  • 财政年份:
    2019
  • 资助金额:
    $ 192.36万
  • 项目类别:
The impact of early Tau pathology on cognitive progression and neuropsychiatric symptoms in Parkinson's disease
早期 Tau 病理学对帕金森病认知进展和神经精神症状的影响
  • 批准号:
    10401958
  • 财政年份:
    2019
  • 资助金额:
    $ 192.36万
  • 项目类别:
The impact of early Tau pathology on cognitive progression and neuropsychiatric symptoms in Parkinson's disease
早期 Tau 病理学对帕金森病认知进展和神经精神症状的影响
  • 批准号:
    10674733
  • 财政年份:
    2019
  • 资助金额:
    $ 192.36万
  • 项目类别:
The impact of early Tau pathology on cognitive progression and neuropsychiatric symptoms in Parkinson's disease
早期 Tau 病理学对帕金森病认知进展和神经精神症状的影响
  • 批准号:
    10022179
  • 财政年份:
    2019
  • 资助金额:
    $ 192.36万
  • 项目类别:
Tracking the invaders in multiple sclerosis: Highly specific TREM1-targeted PET imaging of toxic infiltrating myeloid cells and early treatment response.
追踪多发性硬化症中的入侵者:毒性浸润骨髓细胞的高度特异性 TREM1 靶向 PET 成像和早期治疗反应。
  • 批准号:
    9651665
  • 财政年份:
    2018
  • 资助金额:
    $ 192.36万
  • 项目类别:
Modulating the post-stroke inflammatory response to improve outcome in models of cerebral ischemia
调节中风后炎症反应以改善脑缺血模型的结果
  • 批准号:
    10162676
  • 财政年份:
    2018
  • 资助金额:
    $ 192.36万
  • 项目类别:
Modulating the post-stroke inflammatory response to improve outcome in models of cerebral ischemia
调节中风后炎症反应以改善脑缺血模型的结果
  • 批准号:
    9920227
  • 财政年份:
    2018
  • 资助金额:
    $ 192.36万
  • 项目类别:

相似海外基金

CRCNS: Deep Learning to Discover Neurovascular Disruptions in Alzheimer's Disease
CRCNS:深度学习发现阿尔茨海默病的神经血管破坏
  • 批准号:
    10831259
  • 财政年份:
    2023
  • 资助金额:
    $ 192.36万
  • 项目类别:
ARMCADA - Advancing Reliable Measurement in Cognitive Aging and Decision-making Ability
ARMCADA - 推进认知老化和决策能力的可靠测量
  • 批准号:
    10663728
  • 财政年份:
    2023
  • 资助金额:
    $ 192.36万
  • 项目类别:
Saliva based protein markers for predicting the risk of cognitive decline and dementia in older adults.
基于唾液的蛋白质标记物可预测老年人认知能力下降和痴呆的风险。
  • 批准号:
    10662974
  • 财政年份:
    2023
  • 资助金额:
    $ 192.36万
  • 项目类别:
Chronic Pain and Risk of Alzheimer's-Related Neurodegeneration
慢性疼痛和阿尔茨海默病相关神经变性的风险
  • 批准号:
    10644253
  • 财政年份:
    2023
  • 资助金额:
    $ 192.36万
  • 项目类别:
Exercise adherence and cognitive decline: Engaging with the Black community to develop and test a goal-setting and exercise intensity intervention
运动坚持和认知能力下降:与黑人社区合作制定和测试目标设定和运动强度干预措施
  • 批准号:
    10767102
  • 财政年份:
    2023
  • 资助金额:
    $ 192.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了